The Discounted Cash Flow (DCF) valuation of Cellectis SA (ALCLS.PA) is (19.17) EUR. With the latest stock price at 4.20 EUR, the upside of Cellectis SA based on DCF is -556.9%.
Based on the latest price of 4.20 EUR and our DCF valuation, Cellectis SA (ALCLS.PA) is a sell. selling ALCLS.PA stocks now will result in a potential gain of 556.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 8.7% | 6.9% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (213.04) - (10.61) | (19.17) |
| Upside | -5178.3% - -352.9% | -556.9% |